Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125232283 | 12523228 | 3 | F | 20151010 | 20160727 | 20160702 | 20160802 | EXP | GB-AMGEN-GBRSP2015102675 | AMGEN | 58.00 | YR | A | F | Y | 0.00000 | 20160802 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125232283 | 12523228 | 1 | PS | XGEVA | DENOSUMAB | 1 | Subcutaneous | 120 MG, UNK | U | 1066297 | 125320 | 120 | MG | SOLUTION FOR INJECTION | |||||
| 125232283 | 12523228 | 2 | SS | ALCOHOL. | ALCOHOL | 1 | Unknown | 0 | |||||||||||
| 125232283 | 12523228 | 3 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 600 MG, UNK | 0 | 600 | MG | ||||||||
| 125232283 | 12523228 | 4 | SS | APREPITANT. | APREPITANT | 1 | Unknown | UNK | 0 | ||||||||||
| 125232283 | 12523228 | 5 | SS | CLEXANE | ENOXAPARIN SODIUM | 1 | Unknown | 0 | |||||||||||
| 125232283 | 12523228 | 6 | SS | ALIMTA | PEMETREXED DISODIUM | 1 | Unknown | 0 | |||||||||||
| 125232283 | 12523228 | 7 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | Unknown | 0 | |||||||||||
| 125232283 | 12523228 | 8 | C | NEULASTA | PEGFILGRASTIM | 1 | 0 | UNKNOWN FORMULATION | |||||||||||
| 125232283 | 12523228 | 9 | C | CISPLATIN. | CISPLATIN | 1 | 0 | ||||||||||||
| 125232283 | 12523228 | 10 | C | ZOMETA | ZOLEDRONIC ACID | 1 | 0 | ||||||||||||
| 125232283 | 12523228 | 11 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Unknown | UNK | 0 | ||||||||||
| 125232283 | 12523228 | 12 | C | METOCLOPRAMID | METOCLOPRAMIDE | 1 | Intravenous (not otherwise specified) | 20 MG, UNK | 0 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125232283 | 12523228 | 1 | Product used for unknown indication |
| 125232283 | 12523228 | 2 | Product used for unknown indication |
| 125232283 | 12523228 | 3 | Product used for unknown indication |
| 125232283 | 12523228 | 4 | Product used for unknown indication |
| 125232283 | 12523228 | 5 | Thrombosis |
| 125232283 | 12523228 | 6 | Product used for unknown indication |
| 125232283 | 12523228 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125232283 | 12523228 | OT |
| 125232283 | 12523228 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125232283 | 12523228 | Abdominal pain | |
| 125232283 | 12523228 | Abdominal pain upper | |
| 125232283 | 12523228 | Ageusia | |
| 125232283 | 12523228 | Alopecia | |
| 125232283 | 12523228 | Anxiety | |
| 125232283 | 12523228 | Arthralgia | |
| 125232283 | 12523228 | Arthropod bite | |
| 125232283 | 12523228 | Asthenia | |
| 125232283 | 12523228 | Back pain | |
| 125232283 | 12523228 | Blood urine present | |
| 125232283 | 12523228 | Buccal mucosal roughening | |
| 125232283 | 12523228 | Campylobacter infection | |
| 125232283 | 12523228 | Chest discomfort | |
| 125232283 | 12523228 | Chest pain | |
| 125232283 | 12523228 | Confusional state | |
| 125232283 | 12523228 | Constipation | |
| 125232283 | 12523228 | Cough | |
| 125232283 | 12523228 | Decreased appetite | |
| 125232283 | 12523228 | Diarrhoea | |
| 125232283 | 12523228 | Dry mouth | |
| 125232283 | 12523228 | Dry skin | |
| 125232283 | 12523228 | Dysgeusia | |
| 125232283 | 12523228 | Dysphonia | |
| 125232283 | 12523228 | Eating disorder | |
| 125232283 | 12523228 | Epistaxis | |
| 125232283 | 12523228 | Erythema | |
| 125232283 | 12523228 | Fatigue | |
| 125232283 | 12523228 | Feeding disorder | |
| 125232283 | 12523228 | Flatulence | |
| 125232283 | 12523228 | Haemoglobin decreased | |
| 125232283 | 12523228 | Headache | |
| 125232283 | 12523228 | Hot flush | |
| 125232283 | 12523228 | Hypertension | |
| 125232283 | 12523228 | Insomnia | |
| 125232283 | 12523228 | Joint deposit | |
| 125232283 | 12523228 | Lacrimation increased | |
| 125232283 | 12523228 | Mouth ulceration | |
| 125232283 | 12523228 | Muscle tightness | |
| 125232283 | 12523228 | Musculoskeletal chest pain | |
| 125232283 | 12523228 | Musculoskeletal discomfort | |
| 125232283 | 12523228 | Musculoskeletal stiffness | |
| 125232283 | 12523228 | Nausea | |
| 125232283 | 12523228 | Neuropathy peripheral | |
| 125232283 | 12523228 | Non-cardiac chest pain | |
| 125232283 | 12523228 | Oropharyngeal pain | |
| 125232283 | 12523228 | Pain in extremity | |
| 125232283 | 12523228 | Paraesthesia | |
| 125232283 | 12523228 | Poor quality sleep | |
| 125232283 | 12523228 | Productive cough | |
| 125232283 | 12523228 | Pulmonary thrombosis | |
| 125232283 | 12523228 | Rash | |
| 125232283 | 12523228 | Rash macular | |
| 125232283 | 12523228 | Renal artery occlusion | |
| 125232283 | 12523228 | Restlessness | |
| 125232283 | 12523228 | Sinusitis | |
| 125232283 | 12523228 | Tearfulness | |
| 125232283 | 12523228 | Therapeutic response unexpected | |
| 125232283 | 12523228 | Thirst | |
| 125232283 | 12523228 | Tongue ulceration | |
| 125232283 | 12523228 | Urinary tract obstruction | |
| 125232283 | 12523228 | Viral infection | |
| 125232283 | 12523228 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |